28,872 followers
RT @FrontEndocrinol: New Research: Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients: Background and ai…
RT @FrontEndocrinol: New Research: Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients: Background and ai…
RT @FrontEndocrinol: New Research: Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients: Background and ai…
New Research: Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients: Background and aims Animal studies suggested that vildagliptin might exert a beneficial effect on cognitive function. The present… https://t.co/8oMYIrUqEr